Valeant Announces Third Quarter Financial Results Date And Conference Call Details

Montag, 17.10.2016 18:20 von

PR Newswire

LAVAL, Quebec, Oct. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release third quarter 2016 financial results on Tuesday, November 8, 2016, prior to the conference call and live webcast at 8:00 a.m. ET, when the Company will discuss the results.

Conference Call Details


Tuesday, November 8, 2016


8:00 a.m. ET


Participant Event Dial-in 

(877) 876-8393 (North America)

(973) 200-3961 (International) 

Participant Passcode


Replay Dial-in

(855) 859-2056 (North America)

(404) 537-3406 (International) 

Replay Passcode

49468113 (replay available until November 16, 2016)

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

Contact Information:
Elif McDonald
877-281-6642 (toll free)

Renée Soto
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.

Valeant Pharmaceuticals International, Inc.

Logo -


To view the original version on PR Newswire, visit:

SOURCE Valeant Pharmaceuticals International, Inc.